NASDAQ
Amylyx Pharmaceuticals, Inc. (AMLX) has a current ratio of 14.27x as of Monday, May 25, 2026. This represents a 114.82% increase compared to its 12-month average of 6.64x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.